Ares Life Sciences to acquire Esaote - MarketLine Financial Deals

Ares Life Sciences to acquire Esaote

Ares Life Sciences to acquire Esaote - MarketLine Financial Deals
Ares Life Sciences to acquire Esaote
Published Nov 16, 2009
4 pages — Published Nov 16, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Ares Life Sciences, a Switzerland-based private equity firm, has formed a consortium to acquire 100% of the share capital of Esaote S.p.A., an Italy-based manufacturer of medical diagnostic imaging systems.

  
Source:
Document ID
MA13449_091125
Country
Ticker
CRG=IT
Ticker
ISP=IT
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Ares Life Sciences to acquire Esaote" Nov 16, 2009. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Ares-Life-Sciences-to-acquire-Esaote-2052-18287>
  
APA:
MarketLine Financial Deals. (2009). Ares Life Sciences to acquire Esaote Nov 16, 2009. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Ares-Life-Sciences-to-acquire-Esaote-2052-18287>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.